Collaborative work on evaluation of ovarian toxicity 6) Two- or four-week repeated-dose studies and fertility study of cisplatin in female rats

Journal of Toxicological Sciences

Volumn 34, Issue 1 SPEC. ISS., 2009, Pages

  Nozaki, Yusuke ^a   Furubo, Eiko ^a   Matsuno, Takayuki ^a   Fukui, Rie ^a   Kizawa, Kazuo ^a   Kozaki, Tsukasa ^a   Sanzen, Takahiro ^a  

^a TOYAMA CHEMICAL CO LTD   (Japan)

Author keywords

Cisplatin; Ovarian toxicity; Rat

Indexed keywords

CISPLATIN; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; COPULATION; CORPUS LUTEUM; FEMALE; FEMALE FERTILITY; HISTOPATHOLOGY; MATING; NONHUMAN; OVARY; OVARY FOLLICLE; OVARY FOLLICLE ATRESIA; PREGNANCY; RAT; REPRODUCTIVE TOXICITY; ANIMAL; ANIMAL EMBRYO; APOPTOSIS; BODY WEIGHT; DRUG ADMINISTRATION; DRUG EFFECT; EATING; FERTILITY; HEALTH CARE ORGANIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; JAPAN; LONGEVITY; MALE; METABOLISM; METHODOLOGY; MOTOR ACTIVITY; NIDATION; ORGAN SIZE; PATHOLOGY; SPRAGUE DAWLEY RAT; TOXICITY TESTING; UTERUS; VAGINA;

ANIMALIA; RATTUS;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BODY WEIGHT; CISPLATIN; COPULATION; DRUG ADMINISTRATION SCHEDULE; EATING; EMBRYO IMPLANTATION; EMBRYO, MAMMALIAN; FEMALE; FERTILITY; INJECTIONS, INTRAPERITONEAL; JAPAN; LONGEVITY; MALE; MOTOR ACTIVITY; ORGAN SIZE; OVARIAN FOLLICLE; OVARY; PREGNANCY; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; RATS; RATS, SPRAGUE-DAWLEY; SOCIETIES, SCIENTIFIC; TOXICITY TESTS; UTERUS; VAGINA;

EID: 64949167313     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.34.s73     Document Type: Article

References (33)

1. Anabuki, K., Kitajima, S., Kouda, S. and Takahashi, N. (1982):Reproduction studies on cisplatin (I) -Fertility study in rats-. Jpn. Pharmacol. Ther., 10, 659-671.
2. Ataya, K.M., McKanna, J.A., Weintraub, A.M., Clark, M.R. and LeMaire, W.J. (1985): A luteinizing hormone-releasing hormone agonist for the prevention of chemotherapy-induced ovarian follicular loss in rats. Cancer res., 45, 3651-3656.
3. Ataya, K.M., Valeriote, F.A. and Ramahi-Ataya, A.J. (1989): Effect of cyclophosphamide on the immature rat ovary. Cancer res., 49, 1660-1664.
4. Ataya, K.M., Pydyn, E.F. and Ramahi-Ataya, A.J. (1990): The effect of "activated" cyclophosphamide on human and rat ovarian granulosa cells in vitro. Reprod. Toxicol., 4, 121-125.
5. Bartlett, M.S. (1937): Properties of sufficiency and statistical tests. Proc. Roy. Soc. London Ser. A, 160, 268-282.
6. Borovskaya, T.G., Goldberg, V.E., Fomina, T.I., Pakhomova, A.V., Kseneva, S.I., Poluektova, M.E. and Goldberg, E.D. (2004): Morphological and functional state of rat ovaries in early and late periods after administration of platinum cytostatics. Bull. Exp. Biol. Med., 137, 331-335.
7. Butcher, R.L. and Kirkpatrick-Keller, D. (1984): Patterns of follicular growth during the four-day estrous cycle of the rat. Biol. Reprod., 31, 280-286.
8. Dobyan, D.C., Levi, J., Jacobs, C., Kosek, J. and Weiner, M.W. (1980): Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. J. Pharmacol. Exp. Ther., 213, 551-556.
9. Dunnett, C.W. (1964): New tables for multiple comparisons with a control. Biometrics, 20, 482-491.
10. Fisher, R.A. and Yates, F. (1963): Statistical tables for biological, agricultural and medical research, 6th ed., Oliver and Boyd, Edinburgh.
11. Hirshfield, A.N. and Midgley, A.R.Jr. (1978): Morphometric analysis of follicular development in the rat. Biol. Reprod., 19, 597-605.
12. Hoyer, P.B. and Sipes, I.G. (1996): Assessment of follicle destruction in chemical-induced ovarian toxicity. Annu. Rev. Pharmacol. Toxicol., 36, 307-331.
13. Hughes, F.M.Jr. and Gorospe, W.C. (1991): Biochemical identification of apoptosis (programmed cell death) in granulosa cells: evidence for a potential mechanism underlying follicular atresia. Endocrinology, 129, 2415-2422.
14. Kasparkova, J. and Brabec, V. (1995): Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and it strans isomer by DNA-binding proteins. Biochemistry, 34, 12379-12387.
15. Keller, K.A. and Aggarwal, S.K. (1983): Embryotoxicity of cisplatin in rats and mice. Toxicol. Appl. Pharmacol., 69, 245-256.
16. Lopez, S.G. and Luderer, U. (2004): Effects of cyclophosphamide and buthionine sulfoximine on ovarian glutathione and apoptosis. Free Radic. Biol. Med., 36, 1366-1377.
17. Matsuo, G., Ushijima, K., Shinagawa, A., Takahashi, S., Fujiyoshi, N., Takemoto, S., Terada, A., Fukui, A. and Kamura, T. (2007): GnRH agonist acts as ovarian protection in chemotherapy induced gonadotoxicity: an experiment using a rat model. Kurume. Med. J., 54, 25-29.
18. Molina, J.R., Barton, D.L. and Loprinzi, C.L. (2005): Chemotherapy-induced ovarian failure: manifestations and management. Drug Saf., 28, 401-416.
19. Morikawa, S., Sekiya, S., Naitoh, M., Iwasawa, H., Takeda, B. and Takamizawa, H. (1982): Spontaneous occurrence of atypical hyperplasia and adenocarcinoma of the uterus in androgen-sterilized SD rats. J. Natl. Cancer Inst., 69, 95-101.
20. Muskhelishvili, L., Wingard, S.K. and Latendresse, J.R. (2005): Proliferating cell nuclear antigen - a marker for ovarian follicle counts. Toxicol. Pathol., 33, 365-368.
21. Nakai, Y., Konishi, K., Chang, K.C., Ohashi, K., Morisaki, N., Minowa, Y. and Morimoto, A. (1982): Ototoxicity of the anti cancer drug cisplatin. an experimental study. Acta Otolaryngol., 93, 227-232.
22. Pedersen, T. and Peters, H. (1968): Proposal for a classification of oocytes and follicles in the mouse ovary. J. Reprod. Fert., 17, 555-557.
23. Rajakoski, E. (1960): The ovarian follicular system in sexually mature heifers with special reference to seasonal, cyclical, end left-right variation. Acta Endocrinol. Suppl. (copenh)., 34, 1-68.
24. Screnci, D. and Mckeage, M.J. (1999): Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approaches. J. Inorg. Biochem., 77, 105-110.
25. Shinagawa, A. (1998): Cisplatin induced ovarian toxicity study in rats -an experimental analysis-. J. Kurume Med. Assoc., 61, 220-226.
26. Shiromizu, K., Thorgeirsson, S.S. and Mattison, D.R. (1984): Effect of cyclophosphamide on oocyte and follicle number in Sprague-Dawley rats, C57BL/6N and DBA/2N mice. Pediatr. Pharmacol. (New York), 4, 213-221.
27. Steel, R.G.D. (1959): A multiple comparison rank sum test: Treatments versus control. Biometrics, 15, 560-572.
28. Tsubosaki, M., Hagiwara, T., Ito, K., Irie, Y. and Matsuda, A.(1981): A safety study of the cisplatin (NK801) (the second report) -subacute toxicity study and the recovery study in rat The clinical report, 15, 5687-5718.
29. Waxman, J. (1983): Chemotherapy and the adult gonad: a review. J. R. Soc. Med., 76, 144-148.
30. Yeh, J., Kim, B., Liang, Y.J. and Peresie, J. (2006): Mullerian inhibiting substance as a novel biomarker of cisplatin-induced ovarian damage. Biochem. Biophys. Res. Commun., 348, 337-344.
31. Yerushalmi, A. and Yagil, G. (1980): The interaction of chromatin with alkylating agents. The monofunctional action of bis(2-chloroethyl)methylamine. Eur. J. Biochem., 103, 237-246.
32. Yucebilgin, M.S., Terek, M.C., Ozsaran, A., Akercan, F., Zekioglu, O., Isik, E. and Erhan, Y. (2004): Effect of chemotherapy on primordial follicular reserve of rat: an animal model of premature ovarian failure and infertility. Aust. N. Z. J. Obstet. Gynaecol., 44, 6-9.
33. Zwelling, L.A. and Kohn, K.W. (1979): Mechanism of action of cis-dichlorodiammineplatinum(II). Cancer Treat. Rep., 63, 1439-1444.